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Idiopathic pulmonary hemosiderosis (IPH) is one of the rare causes of diffuse alveolar hemorrhage (DAH),
and usually occurs in children. The mechanism underlying this disease development has not been
deﬁned. During the acute phase, death due to massive alveolar hemorrhage and subsequent severe
respiratory failure with multiple organ failure often occurs. We report a case of IPH which occurred in an
advanced-aged adult during following thyroidectomy for chronic thyroiditis. Following surgery this 83-
year-old male developed acute onset dyspnea and pulmonary hemorrhage. In a search for underlying
causes, no disorders were found and the only ﬁnding was the presence of anti-thyroid antibody. Systemic
corticosteroid therapy was effective and he fully recovered. To our knowledge, this is the second
documentation of IPH in association with chronic thyroiditis.
 2009 Elsevier Ltd. All rights reserved.1. Introduction
Idiopathic pulmonary hemosiderosis (IPH) is a rare disease that
causes diffuse alveolar hemorrhage (DAH),1 characterized by
recurrent episodes of hemoptytis and diffuse pulmonary inﬁltrates.
Previous reports suggest that some appear to be associated with
cow’s milk allergy,2 and celiac disease,3 and most cases reported
were in children.1 Death may occur suddenly from acute pulmo-
nary hemorrhage or progressive respiratory failure.4 The exact
etiology of this disease is not deﬁned, and there are no speciﬁc
treatments. Some observational studies suggest that corticoste-
roids or corticosteroids in combination with other immunosup-
pressive agents are effective for either exacerbations or
maintenance therapy of IPH.1,4 These clinical ﬁndings indicate that
an immunologic cause may be involved in the development of IPH.
Here, we present a rare case of IPH occurred which in an
advanced-aged adult during the follow-up of chronic thyroiditis,
and rescued by systemic steroid therapy.
2. Case report
An 83-year-old man with a history of chronic thyroiditis
underwent a thyroidectomy. Within a month he presented withmatology, Oncology, Allergy
aduate School of Medicine,
ta-cho, Okayama 700-8558,
. Miyahara).
rved.hemoptysis. The patient stated that before the onset of these
symptoms, he was in his usual state of health, denying recent fever,
chills, chest pain, or weight loss. The patient had a history of
laryngectomy for laryngeal cancer several years earlier. He became
aware of increasing bloody sputum, so laryngoscopy was per-
formed, but it showed no signiﬁcant abnormality. However, the
persistence of hemoptytis, together with shortness of breath
gradually led him to revisit the hospital. A repeat laryngoscopy was
performed, but no abnormalities were discovered. He was referred
to the Division of Respiratory Medicine.
Physical examination on admission revealed his temperature of
36.2 C, blood pressure 108/72 mmHg, pulse 78/min, and respira-
tory frequency 15/min. On auscultation, diffuse ﬁne crackles were
heard in the both lungs, and no systolic or diastolic murmurs were
detected. A chest X-ray revealed alveolar and interstitial inﬁltrates
of both lungs (Fig. 1). A CT scan of the chest also demonstrated
scattered ground-glass areas in both lung ﬁelds (Fig. 2). Arterial
blood gases (room air) were pH 7.43, PaO2 73.8 mmHg, and PCO2
35.4 mmHg. Pulmonary function could not bemeasured because of
breathlessness. An echocardiogram demonstrated normal cardiac
function. Regarding laboratory ﬁndings, renal and liver function
tests were normal.
The patient was evaluated for the intra-alveolar hemorrhagic
syndromes. Among the tests, serum IgG, IgA, and IgM levels, and C3
and C4 levels were normal. Perinuclear anti-neutrophil cytoplasmic
antibodies and cytoplasmic anti-neutrophil cytoplasmic antibodies
were negative. Anti-nuclear antibodies, anti-ds DNA and anti-
glomerular basal membrane antibodies were negative. Other
Fig. 1. An X-ray ﬁlm of the chest on admission showed alveolar and interstitial inﬁl-
trates of both lungs.
Table 1
Autoimmune antibody panel.
P-ANCA (EU) <10 (<19)
C-ANCA (EU) <10 (<10)
Anti-GBM (EU) <10 (<9)
Anti-TG (IU/ml) 403.3 (<13.5)
Anti-TPO (IU/ml) 117.0 (<3.1)
P-ANCA: perinuclear anti-neutrophil cytoplasmic antibodies. C-ANCA: cytoplasmic
anti-neutrophil cytoplasmic antibodies. Anti-GBM: anti-glomerular basement
membrane antibodies. Anti-TG: anti-thyroglobulin antibodies. Anti-TPO: anti-
thyroid peroxidase auto-antibodies.
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Only anti-thyroglobrin antibodies and anti-thyroid peroxidase
antibodies were highly elevated (Table 1).
On the third day of hospitalization, a bronchoscopy was per-
formed, and revealed a hemorrhagic return from the distal alveoli
consistent with diffuse alveolar hemorrhage. Bronchial alveolar
lavage (BAL) demonstrated abundant haemosiderin-laden macro-
phages (Fig. 3). Culture of the BAL ﬂuid was sterile.
On the basis of these ﬁndings, the patient was diagnosed as IPH
andwas begun on a regimen of high dose corticosteroids (1000 mg/
day) that was tapered gradually to 5 mg/day. The patient’s condi-
tion, as well as CT ﬁndings, improved progressively and he regained
strength gradually. He became asymptomatic and no recurrence
occurred.Fig. 2. A CT scan of the chest demonstrated areas of ground-glass attenuation and
a reticular micronodular appearance in both lung ﬁelds. High dose corticosteroids led
to diffuse ground-glass attenuation.3. Discussion
We describe a very rare case of IPH associated with chronic
thyroiditis in an elderly male. To the best of our knowledge, only
one case of IPH in association with chronic thyroiditis has been
previously reported.5 Diffuse alveolar hemorrhage (DAH) is char-
acterized by widespread hemorrhage from the microvasculature of
the lung into the alveolar spaces. Such pulmonary hemorrhage,
although it is uncommon, can occur in association with a wide
variety of clinical disorders, many of which have overlapping
features of glomerulonephritis, immune complex disease, and anti-
glomerular basement membrane disease.6 In our case, however,
renal function was normal and serum anti-glomerular antibodies
were negative. He also had no evidence of systemic vasculitis,
collagen vascular disorders, infection, cancer, pulmonary embolism
or other conditions, which may be associated with DAH.
Alberda et al. previously divided DAH into six categories.6 This
classiﬁcation is shown in a Venn diagram that classiﬁes DAH into
categories based on association with renal disease (usually
glomerulonephritis), and two immunologic mechanisms: anti-
GBM antibodies or immune complexes. Based on this classiﬁcation,
our case is categorized as idiopathic pulmonary hemosiderosis
(IPH). However, from a clinical point of view and the favorable
response to high dose corticosteroid, an immunopathological
mechanism may have been involved in this unusual case of IPH.
Previous reports also showed that appropriate immunosuppressive
therapy without delay may be effective in IPH.1
It was notable that chronic thyroiditis was also present. Rabec et
al. reported a case of DAH, neither capillaritis nor diffuse alveolar
damage, in association with inﬂammatory bowel disease and
chronic thyroiditis.5 On the one hand, association between DAHFig. 3. Iron stain performed on bronchial alveolar lavage (BAL) specimens, highlighting
the abundant intra-alveolar siderophages.
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previously been reported. On the other hand, although an associ-
ation between chronic thyroiditis and DPH has not been proved,
there is evidence of a strong association with CD and several
immune-mediated diseases, including autoimmune thyroid disor-
ders.7 Previous reports have revealed that some of these conditions
share HLA haplotypes and non-HLA alleles, e.g., cytotoxic T-
lymphocyte-associated antigen-4 (CTLA-4), which may underlie
their pathogenesis.7 Indeed, some reports have previously shown
that a small number of patients with autoimmune thyroiditis were
found to have CD and villous atrophy.7–10 These reports suggest
that chronic thyroiditis as well as CD may trigger DAH through as
yet unknown mechanisms.
In the present case, one might consider the possibility that
a history of chronic thyroiditis and the eventual thyroidectomy
triggered DAH which set off the disease as seen in patients with
celiac disease. Although DAH associated with chronic thyroiditis is
very rare, and has been reported only once before, a search for anti-
thyroid antibodies may be warranted in cases of DAH where the
initiating event is unclear.
In conclusion, we describe the possible association of DAH with
chronic thyroiditis and/or thyroidectomy.Conﬂict of interest
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